Preventing COVID-19 in Healthcare Workers With HCQ: A RCT
Status:
Withdrawn
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
Healthcare workers (HCW) at risk of Covid-19 will have baseline serology for SARS-CoV-2 to
see if they are already immune to Covid-19. HCW will get baseline assessment and if meeting
inclusion criteria and no exclusion criteria they will be randomized in a 2:1 ratio to
hydroxychloroquine or Vitamin C on a weekly basis for three months. Subjects will complete
daily diary of symptoms and temperature, and will have repeat SARS-CoV-2 serology at 6 weeks
and 3 months to determine seroconversion.